What is the recommended dose of Pepcid (famotidine) for a 67-pound male with urticaria (hives)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Famotidine Dosing for a 67-pound Male with Urticaria (Hives)

For a 67-pound (30.4 kg) male with urticaria, the recommended dose of famotidine is 0.5 mg/kg/dose, which equals approximately 15 mg given twice daily. 1

Dosing Rationale and Calculation

Famotidine is an H2-receptor antagonist that can be used as part of the treatment approach for urticaria. When calculating the appropriate dose:

  • Weight-based dosing: 0.5 mg/kg/dose
  • Patient weight: 67 pounds = 30.4 kg
  • Calculated dose: 30.4 kg × 0.5 mg/kg = 15.2 mg per dose
  • Practical dose: 15 mg twice daily

Treatment Approach for Urticaria

First-line Treatment

  • Second-generation H1-antihistamines should be the primary treatment for urticaria 1
    • Examples: cetirizine 10 mg, loratadine 10 mg, or fexofenadine 180 mg daily
    • For children: weight-appropriate dosing of these medications

Role of H2-Antagonists (Famotidine)

  • Famotidine can be added as an adjunctive therapy to H1-antihistamines 1, 2
  • Studies show famotidine can reduce pruritus and intensity of urticaria without causing significant sedation 2
  • Famotidine is approximately 20-50 times more potent than cimetidine and 8 times more potent than ranitidine on a weight basis 3

Escalation of Treatment

If symptoms persist despite standard antihistamine therapy:

  1. Increase H1-antihistamine dose up to 4 times the standard dose 1
  2. Add famotidine as adjunctive therapy
  3. Consider leukotriene receptor antagonists for resistant cases 1
  4. For severe cases unresponsive to above measures, consider omalizumab or cyclosporine 1

Important Considerations

Monitoring

  • Assess treatment response within 1-2 weeks of initiating therapy 1
  • Monitor for signs of anaphylaxis, which would require immediate epinephrine administration 1

Potential Pitfalls

  • Avoid sedating (first-generation) antihistamines, especially in children and elderly patients, due to cognitive impairment risk 1
  • Famotidine is primarily eliminated by the kidneys (72% of the dose recovered unchanged in urine), so dose adjustment may be needed in renal impairment 4
  • Long-term use of oral corticosteroids should be avoided, especially in children 1

Patient Education

  • Identify and avoid potential triggers for urticaria 1
  • Educate regarding signs and symptoms of anaphylaxis 1
  • Advise that individual urticarial lesions typically last 2-24 hours; persistence beyond 24 hours may suggest urticarial vasculitis requiring different management 1

By combining H1-antihistamines with famotidine at the appropriate dose, most patients with urticaria will experience significant symptom relief. If symptoms persist, escalation to higher antihistamine doses or additional therapies should be considered.

References

Guideline

Urticaria Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Famotidine in the treatment of acute urticaria.

Clinical and experimental dermatology, 2000

Research

Pharmacokinetics of famotidine in man.

International journal of clinical pharmacology, therapy, and toxicology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.